Is Natera Inc (NTRA) overvalued? · rev $1.70B
Natera Inc (NTRA) is a diagnostics & research company listed on NASDAQ.
This page asks whether Natera Inc (NTRA) looks expensive on cached numbers — not a short thesis.
Latest reported NTRA revenue for 2024-12-31 was $1.70B. Net income was -$190.4M. Revenue was up 56.7% from 2023-12-31 to 2024-12-31. NTRA currently screens at market cap $33.16B.
NTRA currently screens at market cap $33.16B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NTRA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NTRA stock page for the full model, not this heading.
Not investment advice.